Global T-cell Bispecific Antibodies Drug Market Research Report 2023

Report ID: 1815791 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 T-cell Bispecific Antibodies Drug Market Overview
    1.1 Product Overview and Scope of T-cell Bispecific Antibodies Drug
    1.2 T-cell Bispecific Antibodies Drug Segment by Type
        1.2.1 Global T-cell Bispecific Antibodies Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Blincyto
        1.2.3 Kimmtrak
    1.3 T-cell Bispecific Antibodies Drug Segment by Application
        1.3.1 Global T-cell Bispecific Antibodies Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Hematological Cancers
        1.3.3 Solid Tumors
    1.4 Global T-cell Bispecific Antibodies Drug Market Size Estimates and Forecasts
        1.4.1 Global T-cell Bispecific Antibodies Drug Revenue 2017-2028
        1.4.2 Global T-cell Bispecific Antibodies Drug Sales 2017-2028
        1.4.3 T-cell Bispecific Antibodies Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 T-cell Bispecific Antibodies Drug Market Competition by Manufacturers
    2.1 Global T-cell Bispecific Antibodies Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global T-cell Bispecific Antibodies Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global T-cell Bispecific Antibodies Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers T-cell Bispecific Antibodies Drug Manufacturing Sites, Area Served, Product Type
    2.5 T-cell Bispecific Antibodies Drug Market Competitive Situation and Trends
        2.5.1 T-cell Bispecific Antibodies Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest T-cell Bispecific Antibodies Drug Players Market Share by Revenue
        2.5.3 Global T-cell Bispecific Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 T-cell Bispecific Antibodies Drug Retrospective Market Scenario by Region
    3.1 Global T-cell Bispecific Antibodies Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global T-cell Bispecific Antibodies Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America T-cell Bispecific Antibodies Drug Market Facts & Figures by Country
        3.3.1 North America T-cell Bispecific Antibodies Drug Sales by Country
        3.3.2 North America T-cell Bispecific Antibodies Drug Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe T-cell Bispecific Antibodies Drug Market Facts & Figures by Country
        3.4.1 Europe T-cell Bispecific Antibodies Drug Sales by Country
        3.4.2 Europe T-cell Bispecific Antibodies Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific T-cell Bispecific Antibodies Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific T-cell Bispecific Antibodies Drug Sales by Region
        3.5.2 Asia Pacific T-cell Bispecific Antibodies Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America T-cell Bispecific Antibodies Drug Market Facts & Figures by Country
        3.6.1 Latin America T-cell Bispecific Antibodies Drug Sales by Country
        3.6.2 Latin America T-cell Bispecific Antibodies Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa T-cell Bispecific Antibodies Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa T-cell Bispecific Antibodies Drug Sales by Country
        3.7.2 Middle East and Africa T-cell Bispecific Antibodies Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global T-cell Bispecific Antibodies Drug Historic Market Analysis by Type
    4.1 Global T-cell Bispecific Antibodies Drug Sales Market Share by Type (2017-2022)
    4.2 Global T-cell Bispecific Antibodies Drug Revenue Market Share by Type (2017-2022)
    4.3 Global T-cell Bispecific Antibodies Drug Price by Type (2017-2022)
5 Global T-cell Bispecific Antibodies Drug Historic Market Analysis by Application
    5.1 Global T-cell Bispecific Antibodies Drug Sales Market Share by Application (2017-2022)
    5.2 Global T-cell Bispecific Antibodies Drug Revenue Market Share by Application (2017-2022)
    5.3 Global T-cell Bispecific Antibodies Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Amgen
        6.1.1 Amgen Corporation Information
        6.1.2 Amgen Description and Business Overview
        6.1.3 Amgen T-cell Bispecific Antibodies Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Amgen T-cell Bispecific Antibodies Drug Product Portfolio
        6.1.5 Amgen Recent Developments/Updates
    6.2 Immunocore
        6.2.1 Immunocore Corporation Information
        6.2.2 Immunocore Description and Business Overview
        6.2.3 Immunocore T-cell Bispecific Antibodies Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Immunocore T-cell Bispecific Antibodies Drug Product Portfolio
        6.2.5 Immunocore Recent Developments/Updates
7 T-cell Bispecific Antibodies Drug Manufacturing Cost Analysis
    7.1 T-cell Bispecific Antibodies Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of T-cell Bispecific Antibodies Drug
    7.4 T-cell Bispecific Antibodies Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 T-cell Bispecific Antibodies Drug Distributors List
    8.3 T-cell Bispecific Antibodies Drug Customers
9 T-cell Bispecific Antibodies Drug Market Dynamics
    9.1 T-cell Bispecific Antibodies Drug Industry Trends
    9.2 T-cell Bispecific Antibodies Drug Market Drivers
    9.3 T-cell Bispecific Antibodies Drug Market Challenges
    9.4 T-cell Bispecific Antibodies Drug Market Restraints
10 Global Market Forecast
    10.1 T-cell Bispecific Antibodies Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of T-cell Bispecific Antibodies Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of T-cell Bispecific Antibodies Drug by Type (2023-2028)
    10.2 T-cell Bispecific Antibodies Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of T-cell Bispecific Antibodies Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of T-cell Bispecific Antibodies Drug by Application (2023-2028)
    10.3 T-cell Bispecific Antibodies Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of T-cell Bispecific Antibodies Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of T-cell Bispecific Antibodies Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global T-cell Bispecific Antibodies Drug Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
    Table 2. Global T-cell Bispecific Antibodies Drug Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
    Table 3. Global T-cell Bispecific Antibodies Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global T-cell Bispecific Antibodies Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global T-cell Bispecific Antibodies Drug Sales (Units) of Key Manufacturers (2017-2022)
    Table 6. Global T-cell Bispecific Antibodies Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global T-cell Bispecific Antibodies Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global T-cell Bispecific Antibodies Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market T-cell Bispecific Antibodies Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers T-cell Bispecific Antibodies Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers T-cell Bispecific Antibodies Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global T-cell Bispecific Antibodies Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-cell Bispecific Antibodies Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global T-cell Bispecific Antibodies Drug Sales by Region (2017-2022) & (Units)
    Table 16. Global T-cell Bispecific Antibodies Drug Sales Market Share by Region (2017-2022)
    Table 17. Global T-cell Bispecific Antibodies Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global T-cell Bispecific Antibodies Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America T-cell Bispecific Antibodies Drug Sales by Country (2017-2022) & (Units)
    Table 20. North America T-cell Bispecific Antibodies Drug Sales Market Share by Country (2017-2022)
    Table 21. North America T-cell Bispecific Antibodies Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America T-cell Bispecific Antibodies Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe T-cell Bispecific Antibodies Drug Sales by Country (2017-2022) & (Units)
    Table 24. Europe T-cell Bispecific Antibodies Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe T-cell Bispecific Antibodies Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe T-cell Bispecific Antibodies Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific T-cell Bispecific Antibodies Drug Sales by Region (2017-2022) & (Units)
    Table 28. Asia Pacific T-cell Bispecific Antibodies Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific T-cell Bispecific Antibodies Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific T-cell Bispecific Antibodies Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America T-cell Bispecific Antibodies Drug Sales by Country (2017-2022) & (Units)
    Table 32. Latin America T-cell Bispecific Antibodies Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America T-cell Bispecific Antibodies Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America T-cell Bispecific Antibodies Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa T-cell Bispecific Antibodies Drug Sales by Country (2017-2022) & (Units)
    Table 36. Middle East and Africa T-cell Bispecific Antibodies Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa T-cell Bispecific Antibodies Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa T-cell Bispecific Antibodies Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global T-cell Bispecific Antibodies Drug Sales by Type (2017-2022) & (Units)
    Table 40. Global T-cell Bispecific Antibodies Drug Sales Market Share by Type (2017-2022)
    Table 41. Global T-cell Bispecific Antibodies Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global T-cell Bispecific Antibodies Drug Revenue Share by Type (2017-2022)
    Table 43. Global T-cell Bispecific Antibodies Drug Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global T-cell Bispecific Antibodies Drug Sales (Units) by Application (2017-2022)
    Table 45. Global T-cell Bispecific Antibodies Drug Sales Market Share by Application (2017-2022)
    Table 46. Global T-cell Bispecific Antibodies Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global T-cell Bispecific Antibodies Drug Revenue Share by Application (2017-2022)
    Table 48. Global T-cell Bispecific Antibodies Drug Price by Application (2017-2022) & (US$/Unit)
    Table 49. Amgen Corporation Information
    Table 50. Amgen Description and Business Overview
    Table 51. Amgen T-cell Bispecific Antibodies Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Amgen T-cell Bispecific Antibodies Drug Product
    Table 53. Amgen Recent Developments/Updates
    Table 54. Immunocore Corporation Information
    Table 55. Immunocore Description and Business Overview
    Table 56. Immunocore T-cell Bispecific Antibodies Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Immunocore T-cell Bispecific Antibodies Drug Product
    Table 58. Immunocore Recent Developments/Updates
    Table 59. Production Base and Market Concentration Rate of Raw Material
    Table 60. Key Suppliers of Raw Materials
    Table 61. T-cell Bispecific Antibodies Drug Distributors List
    Table 62. T-cell Bispecific Antibodies Drug Customers List
    Table 63. T-cell Bispecific Antibodies Drug Market Trends
    Table 64. T-cell Bispecific Antibodies Drug Market Drivers
    Table 65. T-cell Bispecific Antibodies Drug Market Challenges
    Table 66. T-cell Bispecific Antibodies Drug Market Restraints
    Table 67. Global T-cell Bispecific Antibodies Drug Sales Forecast by Type (2023-2028) & (Units)
    Table 68. Global T-cell Bispecific Antibodies Drug Sales Market Share Forecast by Type (2023-2028)
    Table 69. Global T-cell Bispecific Antibodies Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 70. Global T-cell Bispecific Antibodies Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 71. Global T-cell Bispecific Antibodies Drug Sales Forecast by Application (2023-2028) & (Units)
    Table 72. Global T-cell Bispecific Antibodies Drug Sales Market Share Forecast by Application (2023-2028)
    Table 73. Global T-cell Bispecific Antibodies Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 74. Global T-cell Bispecific Antibodies Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 75. Global T-cell Bispecific Antibodies Drug Sales Forecast by Region (2023-2028) & (Units)
    Table 76. Global T-cell Bispecific Antibodies Drug Sales Market Share Forecast by Region (2023-2028)
    Table 77. Global T-cell Bispecific Antibodies Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 78. Global T-cell Bispecific Antibodies Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Research Programs/Design for This Report
    Table 80. Key Data Information from Secondary Sources
    Table 81. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of T-cell Bispecific Antibodies Drug
    Figure 2. Global T-cell Bispecific Antibodies Drug Market Share by Type in 2021 & 2028
    Figure 3. Blincyto Product Picture
    Figure 4. Kimmtrak Product Picture
    Figure 5. Global T-cell Bispecific Antibodies Drug Market Share by Application in 2021 & 2028
    Figure 6. Hematological Cancers
    Figure 7. Solid Tumors
    Figure 8. Global T-cell Bispecific Antibodies Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global T-cell Bispecific Antibodies Drug Market Size (2017-2028) & (US$ Million)
    Figure 10. Global T-cell Bispecific Antibodies Drug Sales (2017-2028) & (Units)
    Figure 11. T-cell Bispecific Antibodies Drug Sales Share by Manufacturers in 2021
    Figure 12. Global T-cell Bispecific Antibodies Drug Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest T-cell Bispecific Antibodies Drug Players: Market Share by Revenue in 2021
    Figure 14. T-cell Bispecific Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global T-cell Bispecific Antibodies Drug Sales Market Share by Region (2017-2022)
    Figure 16. Global T-cell Bispecific Antibodies Drug Sales Market Share by Region in 2021
    Figure 17. Global T-cell Bispecific Antibodies Drug Revenue Market Share by Region (2017-2022)
    Figure 18. Global T-cell Bispecific Antibodies Drug Revenue Market Share by Region in 2021
    Figure 19. United States T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE T-cell Bispecific Antibodies Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of T-cell Bispecific Antibodies Drug by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of T-cell Bispecific Antibodies Drug
    Figure 43. Manufacturing Process Analysis of T-cell Bispecific Antibodies Drug
    Figure 44. T-cell Bispecific Antibodies Drug Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Immunocore
Frequently Asked Questions
T-cell Bispecific Antibodies Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
T-cell Bispecific Antibodies Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
T-cell Bispecific Antibodies Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports